DeepMed Research

MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

Prevalence and Cardiovascular Effects of Growth Hormone Deficiency in Abdominal Obesity

Completed

Conditions: Growth Hormone
Obesity

First Posted Date: 2007-11-22

Last Posted Date: 2011-08-23

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 149

Registration Number: NCT00562796

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Biochemical Brain Changes Correlated With The Antidepressant Effect Of Thyroid Hormones

Not Applicable

Completed

Conditions: Major Depressive Disorder

First Posted Date: 2007-11-22

Last Posted Date: 2007-11-22

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 30

Registration Number: NCT00562367

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Bevacizumab With or Without Sunitinib in Sunitinib-Refractory Renal Cell Carcinoma

Phase 2

Withdrawn

Conditions: Renal Cell Carcinoma

Interventions: Drug: Bevacizumab
Drug: Sunitinib

First Posted Date: 2007-11-09

Last Posted Date: 2016-03-24

Lead Sponsor: Massachusetts General Hospital

Registration Number: NCT00556205

A 12-Week, Placebo Controlled Trial of Ziprasidone as Monotherapy for Major Depressive Disorder

Phase 2

Completed

Conditions: Major Depressive Disorder

Interventions: Drug: Placebo
Drug: Ziprasidone

First Posted Date: 2007-11-09

Last Posted Date: 2014-07-03

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 120

Registration Number: NCT00555997

Locations: 🇺🇸
Psychiatric Medicine Associates, L.L.C., Chicago, Illinois, United States
🇺🇸
Massachusetts General Hosptial, Boston, Massachusetts, United States
🇺🇸
Cambridge Health Alliance, Cambridge, Massachusetts, United States

and more 4 locations

The Combination of Aripiprazole and Antidepressants in Psychotic Major Depression

Phase 3

Completed

Conditions: Psychotic Depression

Interventions: Drug: Aripiprazole

First Posted Date: 2007-11-09

Last Posted Date: 2012-08-20

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 16

Registration Number: NCT00556140

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Hormone Dynamics and Bone Mineral Density in Anorexia Nervosa v. Hypothalamic Amenorrhea

Completed

Conditions: Anorexia Nervosa
Hypothalamic Amenorrhea
Obesity

First Posted Date: 2007-11-09

Last Posted Date: 2020-09-02

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 61

Registration Number: NCT00556036

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma

Phase 2

Completed

Conditions: Neoplasm Metastases
Renal Cell Carcinoma

Interventions: Drug: Gemcitabine
Drug: Sunitinib

First Posted Date: 2007-11-09

Last Posted Date: 2016-04-21

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 72

Registration Number: NCT00556049

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Beth Israel Deaconess Medical Center', Boston, Massachusetts, United States
🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States

Evaluation of the Wear of Vitamin E Treated Polyethylene Components in Primary THA Using RSA

Not Applicable

Conditions: Osteoarthritis of Hip
Traumatic Arthritis of Hip

Interventions: Procedure: Hip replacement

First Posted Date: 2007-11-01

Last Posted Date: 2017-05-03

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 50

Registration Number: NCT00551967

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Intermittent Letrozole Therapy in Postmenopausal Women With Metastatic Breast Cancer

Phase 2

Terminated

Conditions: Breast Cancer

Interventions: Drug: Letrozole

First Posted Date: 2007-10-26

Last Posted Date: 2017-03-22

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 3

Registration Number: NCT00549822

Locations: 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Management of Incidentally Discovered Pancreatic Cysts

Phase 3

Terminated

Conditions: Pancreatic Cyst

Interventions: Other: Ethanol lavage

First Posted Date: 2007-10-26

Last Posted Date: 2008-06-26

Lead Sponsor: Massachusetts General Hospital

Registration Number: NCT00550108

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy